{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:34:14Z","timestamp":1787758454433,"version":"build-2784847793"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Ventilator-associated pneumonia (VAP) with multidrug-resistant (MDR) gram negative organisms is a common problem in intensive care unit (ICU). Aerosolized antibiotics enhance the efficacy of systemic antibiotics when added as adjuvants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>The primary objective of the study was to compare the clinical and bacteriological outcome of patients with VAP who were administered intravenous (IV) antibiotics alone with those patients who were treated with adjunctive nebulized colistin (NC) along with IV antibiotics. The secondary objective was to study the occurrence of any adverse events during colistin nebulization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings and Design:<\/jats:title>\n                    <jats:p>The study was a prospective, randomized, double-blinded controlled study conducted at a tertiary-care teaching institution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Ninety-eight children from surgical ICU aged less than 12 years who were diagnosed with VAP due to gram negative bacteria following cardiac surgery were chosen and divided randomly into two groups. The experimental group (NC group) was treated with systemic antibiotics along with NC, whereas the control group (NS group) was administered systemic antibiotics with nebulized normal saline (NS). Clinical and bacteriological outcomes were noted. Statistical analysis was done using SPSS Version 20.0 software. The patient characteristics were compared using independent Student's t test and Chi-square test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      There was a statistically significant reduction in the duration of mechanical ventilation, postoperative ICU and hospital stay (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05) in the NC group compared with the NS group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Aerosolized colistin may be considered as an adjunct to systemic IV antibiotics in pediatric patients with VAP due to gram negative bacteria susceptible to colistin.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aca.aca_81_21","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T10:50:57Z","timestamp":1665139857000},"page":"435-440","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Randomized Control Study of Nebulized Colistin as an Adjunctive Therapy in Ventilator-Associated Pneumonia in Pediatric Postoperative Cardiac Surgical Population"],"prefix":"10.4103","volume":"25","author":[{"given":"K. S.","family":"Bharathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananda","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gegal","family":"Pruthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parimala P.","family":"Simha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20240901","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s00134-020-05980-0","article-title":"Ventilator-associated pneumonia in adults: A narrative review","volume":"46","author":"Papazian","year":"2020","journal-title":"Intensive Care Med"},{"key":"R2-8-20240901","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4103\/1817-1737.32230","article-title":"Incidence of multidrug resistant organisms causing ventilator-associated pneumonia in a tertiary care hospital: A nine months' prospective study","volume":"2","author":"Dey","year":"2007","journal-title":"Ann Thorac Med"},{"key":"R3-8-20240901","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/CMR.00041-06","article-title":"Ventilator-Associated Pneumonia in neonatal and paediatric intensive care unit patients","volume":"20","author":"Foglia","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"R4-8-20240901","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1086\/432583","article-title":"Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"41","author":"Kwa","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R5-8-20240901","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3121\/cmr.4.2.138","article-title":"The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: A review of the recent literature","volume":"4","author":"Falagas","year":"2006","journal-title":"Clin Med Res"},{"key":"R6-8-20240901","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.rmed.2007.10.011","article-title":"Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: Prospective study","volume":"102","author":"Michalopoulos","year":"2008","journal-title":"Respir Med"},{"key":"R7-8-20240901","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s13054-018-2106-x","article-title":"Aerosolised antibiotics for ventilator associated pneumonia: A pairwise and Bayesian network meta-analysis","volume":"22","author":"Xu","year":"2018","journal-title":"Crit Care"},{"key":"R8-8-20240901","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13613-017-0301-6","article-title":"Nebulized antibiotics in mechanically ventilated patients: A challenge for transational research from technology to clinical care","volume":"7","author":"Ehrmann","year":"2017","journal-title":"Ann Intensive Care"},{"key":"R9-8-20240901","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1128\/CMR.00101-15","article-title":"Inhaled antibiotics for gram- negative resp infections","volume":"29","author":"Wenzler","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"R10-8-20240901","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3390\/microorganisms9061154","article-title":"Nebulized colistin in ventilator-associated pneumonia and tracheobronchitis: Historical background, pharmacokinetics and perspectives","volume":"9","author":"Zhu","year":"2021","journal-title":"Microorganisms"},{"key":"R11-8-20240901","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2017.05.016","article-title":"Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: A systematic review and meta-analysis","volume":"51","author":"Vardakas","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"R12-8-20240901","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R13-8-20240901","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/2110-5820-1-30","article-title":"Colistin: Recent data on pharmacodynamics properties and clinical efficacy in critically ill patients","volume":"1","author":"Michalopoulos","year":"2011","journal-title":"Ann Intensive Care"},{"key":"R14-8-20240901","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13613-016-0127-7","article-title":"Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: A prospective, randomised trial","volume":"6","author":"Abdellatif","year":"2016","journal-title":"Ann Intensive Care"},{"key":"R15-8-20240901","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/ALN.0b013e31827515de","article-title":"Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii","volume":"117","author":"Lu","year":"2012","journal-title":"Anesthesiology"},{"key":"R16-8-20240901","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1469-0691.2009.03040.x","article-title":"Inhaled Colistin as adjunctive therapy to intravenous Colistin for the treatment of microbiologically documented ventilator-associated pneumonia: A comparative cohort study","volume":"16","author":"Korbila","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"R17-8-20240901","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/adc.68.6.788","article-title":"Aerosol antibiotic treatment in cystic fibrosis","volume":"68","author":"Littlewood","year":"1993","journal-title":"Arch Dis Child"},{"key":"R18-8-20240901","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/thx.51.4.364","article-title":"Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: A meta-analysis of benefits and risks","volume":"51","author":"Mukhopadhyay","year":"1996","journal-title":"Thorax"},{"key":"R19-8-20240901","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/clinids\/23.3.641","article-title":"Prolonged efficiency of secondary prophylaxis with Colistin aerosols for respiratory infection due to Pseudomonas aeruginosa in patients infected with human immunodeficiency virus","volume":"23","author":"Zylberberg","year":"1996","journal-title":"Clin Infect Dis"},{"key":"R20-8-20240901","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ppul.21324","article-title":"Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii with aerosolized colistin in neonates: A preliminary report","volume":"46","author":"Nakwan","year":"2011","journal-title":"Pediatr Pulmonol"},{"key":"R21-8-20240901","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00431-009-1137-3","article-title":"Colistin administration to paediatric and neonatal patients","volume":"169","author":"Iosifidis","year":"2010","journal-title":"Eur J Pediatrcs"}],"container-title":["Annals of Cardiac Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aca.aca_81_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:16:55Z","timestamp":1787757415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aca.aca_81_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/aca.aca_81_21","relation":{},"ISSN":["0971-9784"],"issn-type":[{"value":"0971-9784","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}